Outcome or subgroup title,No. of studies,No. of participants,Statistical method,Effect size,comparison_name,comparison_id,effect_size,lower_ci,upper_ci,outcome_id,subgroup_id,outcome_name,subgroup_name
1.1 Number of red blood cells (units) transfused per participant up to 30 days post surgery Show forest plot,3,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Systemic drug treatments,1,,,,1,1,,Number of red blood cells (units) transfused per participant up to 30 days post surgery Show forest plot
1.1.1 Aprotinin vs placebo,1,35,"Mean Difference (IV, Random, 95% CI)","‐1.56 [‐5.65, 2.53]",Systemic drug treatments,1,-1.56,-5.65,2.53,1,1,,Aprotinin vs placebo
1.1.2 Desmopressin vs placebo,2,135,"Mean Difference (IV, Random, 95% CI)","‐0.23 [‐0.87, 0.42]",Systemic drug treatments,1,-0.23,-0.87,0.42,1,1,,Desmopressin vs placebo
1.2 All‐cause mortality at up to 30 days Show forest plot,5,,"Risk Ratio (M‐H, Random, 95% CI)",Subtotals only,Systemic drug treatments,1,,,,1,2,,All‐cause mortality at up to 30 days Show forest plot
1.2.1 Aprotinin vs placebo,3,244,"Risk Ratio (M‐H, Random, 95% CI)","0.96 [0.61, 1.52]",Systemic drug treatments,1,0.96,0.61,1.52,1,2,,Aprotinin vs placebo
1.2.2 Desmopressin vs placebo,1,91,"Risk Ratio (M‐H, Random, 95% CI)","5.57 [0.27, 112.85]",Systemic drug treatments,1,5.57,0.27,112.85,1,2,,Desmopressin vs placebo
1.2.3 Tranexamic acid vs placebo,1,100,"Risk Ratio (M‐H, Random, 95% CI)",Not estimable,Systemic drug treatments,1,,,,1,2,,Tranexamic acid vs placebo
1.3 Risk of receiving any allogeneic blood product at up to 30 days post surgery Show forest plot,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,3,,Risk of receiving any allogeneic blood product at up to 30 days post surgery Show forest plot
1.3.1 Tranexamic acid vs placebo,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,3,,Tranexamic acid vs placebo
1.4 Risk of reoperation or repeat procedure for bleeding within 7 days Show forest plot,2,,"Risk Ratio (M‐H, Random, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,4,,Risk of reoperation or repeat procedure for bleeding within 7 days Show forest plot
1.4.1 Aprotinin vs placebo,1,,"Risk Ratio (M‐H, Random, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,4,,Aprotinin vs placebo
1.4.2 Tranexamic acid vs placebo,1,,"Risk Ratio (M‐H, Random, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,4,,Tranexamic acid vs placebo
"1.5 Risk of a thrombotic/thromboembolic event (MI, CVA, DVT, PE) up to 30‐day follow‐up Show forest plot",2,,"Risk Ratio (M‐H, Random, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,5,,"Risk of a thrombotic/thromboembolic event (MI, CVA, DVT, PE) up to 30‐day follow‐up Show forest plot"
1.5.1 Desmopressin vs placebo,1,,"Risk Ratio (M‐H, Random, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,5,,Desmopressin vs placebo
1.5.2 Tranexamic acid vs placebo,1,,"Risk Ratio (M‐H, Random, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,5,,Tranexamic acid vs placebo
1.6 Risk of myocardial infarction up to 30 days Show forest plot,4,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Subtotals only,Systemic drug treatments,1,,,,1,6,,Risk of myocardial infarction up to 30 days Show forest plot
1.6.1 Aprotinin vs placebo,2,209,"Peto Odds Ratio (Peto, Fixed, 95% CI)","0.41 [0.09, 1.82]",Systemic drug treatments,1,0.41,0.09,1.82,1,6,,Aprotinin vs placebo
1.6.2 Desmopressin vs placebo,1,91,"Peto Odds Ratio (Peto, Fixed, 95% CI)","0.55 [0.11, 2.88]",Systemic drug treatments,1,0.55,0.11,2.88,1,6,,Desmopressin vs placebo
1.6.3 Tranexamic acid vs placebo,1,100,"Peto Odds Ratio (Peto, Fixed, 95% CI)","1.00 [0.14, 7.32]",Systemic drug treatments,1,1.0,0.14,7.32,1,6,,Tranexamic acid vs placebo
1.7 Risk of CVA or stroke up to 30 days Show forest plot,2,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Subtotals only,Systemic drug treatments,1,,,,1,7,,Risk of CVA or stroke up to 30 days Show forest plot
1.7.1 Aprotinin vs placebo,2,209,"Peto Odds Ratio (Peto, Fixed, 95% CI)","0.36 [0.05, 2.62]",Systemic drug treatments,1,0.36,0.05,2.62,1,7,,Aprotinin vs placebo
1.8 Risk of deep vein thrombosis up to 90 days Show forest plot,2,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,8,,Risk of deep vein thrombosis up to 90 days Show forest plot
1.8.1 Aprotinin vs placebo,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,8,,Aprotinin vs placebo
1.8.2 Desmopressin vs placebo,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,8,,Desmopressin vs placebo
1.9 Risk of pulmonary embolism up to 90 days Show forest plot,3,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,9,,Risk of pulmonary embolism up to 90 days Show forest plot
1.9.1 Aprotinin vs placebo,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,9,,Aprotinin vs placebo
1.9.2 Desmopressin vs placebo,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,9,,Desmopressin vs placebo
1.9.3 Tranexamic acid vs placebo,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Systemic drug treatments,1,,,,1,9,,Tranexamic acid vs placebo
2.1 Number of red blood cells (units) transfused per participant up to 30 days Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Topical drug treatments,2,,,,2,1,,Number of red blood cells (units) transfused per participant up to 30 days Show forest plot
2.1.1 Thrombin+fibrin/collagen sponge vs usual care,1,20,"Mean Difference (IV, Random, 95% CI)","‐0.10 [‐0.80, 0.60]",Topical drug treatments,2,-0.1,-0.8,0.6,2,1,,Thrombin+fibrin/collagen sponge vs usual care
2.2 All‐cause mortality at up to 30 days Show forest plot,10,,"Risk Ratio (M‐H, Random, 95% CI)",Subtotals only,Topical drug treatments,2,,,,2,2,,All‐cause mortality at up to 30 days Show forest plot
2.2.1 Thrombin+fibrin/collagen sponge vs usual care,1,22,"Risk Ratio (M‐H, Random, 95% CI)","3.00 [0.14, 66.53]",Topical drug treatments,2,3.0,0.14,66.53,2,2,,Thrombin+fibrin/collagen sponge vs usual care
2.2.2 Human thrombin/gelatin sponge vs bovine thrombin/gelatin sponge,1,31,"Risk Ratio (M‐H, Random, 95% CI)",Not estimable,Topical drug treatments,2,,,,2,2,,Human thrombin/gelatin sponge vs bovine thrombin/gelatin sponge
2.2.3 Collagen dressing vs oxidised cellulose,1,16,"Risk Ratio (M‐H, Random, 95% CI)","3.00 [0.14, 64.26]",Topical drug treatments,2,3.0,0.14,64.26,2,2,,Collagen dressing vs oxidised cellulose
2.2.4 Novel agent/gelatin sponge vs placebo/gelatin sponge,1,54,"Risk Ratio (M‐H, Random, 95% CI)",Not estimable,Topical drug treatments,2,,,,2,2,,Novel agent/gelatin sponge vs placebo/gelatin sponge
2.2.5 Fibrin sealant vs usual care,3,585,"Risk Ratio (M‐H, Random, 95% CI)","0.44 [0.11, 1.76]",Topical drug treatments,2,0.44,0.11,1.76,2,2,,Fibrin sealant vs usual care
2.2.6 Fibrin sealant vs gelatin sponge,1,176,"Risk Ratio (M‐H, Random, 95% CI)","2.46 [0.29, 20.55]",Topical drug treatments,2,2.46,0.29,20.55,2,2,,Fibrin sealant vs gelatin sponge
2.2.7 Fibrin sealant vs thrombin/gelatin sponge,1,199,"Risk Ratio (M‐H, Random, 95% CI)","0.50 [0.09, 2.64]",Topical drug treatments,2,0.5,0.09,2.64,2,2,,Fibrin sealant vs thrombin/gelatin sponge
2.2.8 Synthetic sealant vs thrombin/gelatin sponge,1,89,"Risk Ratio (M‐H, Random, 95% CI)","0.10 [0.01, 1.71]",Topical drug treatments,2,0.1,0.01,1.71,2,2,,Synthetic sealant vs thrombin/gelatin sponge
2.3 Risk of receiving any allogeneic blood product at up to 30 days post surgery Show forest plot,2,,"Risk Ratio (M‐H, Random, 95% CI)",Subtotals only,Topical drug treatments,2,,,,2,3,,Risk of receiving any allogeneic blood product at up to 30 days post surgery Show forest plot
2.3.1 Fibrin/collagen sponge vs usual care,1,60,"Risk Ratio (M‐H, Random, 95% CI)","0.33 [0.12, 0.92]",Topical drug treatments,2,0.33,0.12,0.92,2,3,,Fibrin/collagen sponge vs usual care
2.3.2 Thrombin+fibrin/collagen sponge vs usual care,1,22,"Risk Ratio (M‐H, Random, 95% CI)","0.20 [0.01, 3.74]",Topical drug treatments,2,0.2,0.01,3.74,2,3,,Thrombin+fibrin/collagen sponge vs usual care
2.4 Risk of reoperation or repeat procedure for bleeding within 7 days Show forest plot,3,,"Risk Ratio (M‐H, Random, 95% CI)",Subtotals only,Topical drug treatments,2,,,,2,4,,Risk of reoperation or repeat procedure for bleeding within 7 days Show forest plot
2.4.1 Fibrin sealant vs usual care,1,160,"Risk Ratio (M‐H, Random, 95% CI)","1.03 [0.31, 3.40]",Topical drug treatments,2,1.03,0.31,3.4,2,4,,Fibrin sealant vs usual care
2.4.2 Fibrin sealant vs gelatin sponge,1,175,"Risk Ratio (M‐H, Random, 95% CI)","0.17 [0.01, 4.03]",Topical drug treatments,2,0.17,0.01,4.03,2,4,,Fibrin sealant vs gelatin sponge
2.4.3 Synthetic sealant vs thrombin/gelatin sponge,1,89,"Risk Ratio (M‐H, Random, 95% CI)","0.36 [0.01, 8.51]",Topical drug treatments,2,0.36,0.01,8.51,2,4,,Synthetic sealant vs thrombin/gelatin sponge
"2.5 Risk of a thrombotic/thromboembolic event (MI, CVA, DVT, PE) up to 30‐day follow‐up Show forest plot",6,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,5,,"Risk of a thrombotic/thromboembolic event (MI, CVA, DVT, PE) up to 30‐day follow‐up Show forest plot"
2.5.1 Fibrin/collagen sponge vs usual care,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,5,,Fibrin/collagen sponge vs usual care
2.5.2 Thrombin+fibrin/collagen sponge vs usual care,2,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,5,,Thrombin+fibrin/collagen sponge vs usual care
2.5.3 Collagen dressing vs oxidised cellulose,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,5,,Collagen dressing vs oxidised cellulose
2.5.4 Fibrin sealant vs usual care,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,5,,Fibrin sealant vs usual care
2.5.5 Synthetic sealant vs thrombin/gelatin sponge,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,5,,Synthetic sealant vs thrombin/gelatin sponge
2.6 Risk of a myocardial infarction up to 30 days Show forest plot,4,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,6,,Risk of a myocardial infarction up to 30 days Show forest plot
2.6.1 Thrombin+fibrin/collagen sponge vs usual care,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,6,,Thrombin+fibrin/collagen sponge vs usual care
2.6.2 Collagen dressing vs oxidised cellulose,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,6,,Collagen dressing vs oxidised cellulose
2.6.3 Fibrin sealant vs usual care,2,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,6,,Fibrin sealant vs usual care
2.7 Risk of a CVA or stroke up to 30 days Show forest plot,3,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,7,,Risk of a CVA or stroke up to 30 days Show forest plot
2.7.1 Collagen dressing vs oxidised cellulose,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,7,,Collagen dressing vs oxidised cellulose
2.7.2 fibrin sealant vs usual care,2,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,7,,fibrin sealant vs usual care
2.8 Risk of a deep vein thrombosis up to 90 days Show forest plot,2,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,8,,Risk of a deep vein thrombosis up to 90 days Show forest plot
2.8.1 Collagen dressing vs oxidised cellulose,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,8,,Collagen dressing vs oxidised cellulose
2.8.2 Fibrin sealant vs usual care,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,8,,Fibrin sealant vs usual care
2.9 Risk of a pulmonary embolism up to 90 days Show forest plot,3,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,9,,Risk of a pulmonary embolism up to 90 days Show forest plot
2.9.1 Collagen dressing vs oxidised cellulose,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,9,,Collagen dressing vs oxidised cellulose
2.9.2 Novel agent (Peprostat) vs placebo/gelatin sponge,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,9,,Novel agent (Peprostat) vs placebo/gelatin sponge
2.9.3 Fibrin sealant vs usual care,1,,"Peto Odds Ratio (Peto, Fixed, 95% CI)",Totals not selected,Topical drug treatments,2,,,,2,9,,Fibrin sealant vs usual care
